NCT02577107View on ClinicalTrials.gov

Head to Head Study of Anti-VEGF Treatment.

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 13, 2016

Primary Completion Date

July 9, 2016

Study Completion Date

July 9, 2016

Conditions
Age-related Macular Degeneration
Interventions
DRUG

ranibizumab

DRUG

Conbercept

Trial Locations (1)

610041

Novartis Investigative Site, Chengdu

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY